Skip to main content
. Author manuscript; available in PMC: 2016 Jul 22.
Published in final edited form as: Clin Cancer Res. 2016 Jan 13;22(6):1313–1317. doi: 10.1158/1078-0432.CCR-15-1458

Figure 1.

Figure 1

AXL overexpression and activation of downstream signaling pathways. AXL is overexpressed upon acquisition of therapy resistance and can induce epithelial-to-mesenchymal transition (EMT). It dimerizes with RTKs present in the membrane of tumor cells to initiate signaling cascades that ultimately lead to increased cell motility and survival.